Top Page | English | 简体中文 | 繁體中文 | 한국어 | 日本語
Thursday, 24 March 2022, 10:05 HKT/SGT
Share:
    

Source: Denso
Joint Research Shows that DENSO's Microalga, Coccomyxa sp. KJ Has Virucidal Effect against COVID-19

TOKYO, Mar 24, 2022 - (JCN Newswire) - Chubu University, Tokai University, Tohoku University School of Medicine and DENSO Corporation have found that monogalactosyl diacylglyceride (MGDG), a component contained in the chloroplasts of a microalga called Coccomyxa sp. KJ(1), has a virucidal effect(2) against COVID-19.


Coccomyxa sp. KJ is a fast-growing, vigorous, and easy-to-cultivate microalga. The plant contains not only abundant nutrients, including vitamins and amino acids, but also unique characteristics, such as suppressing an increase in the bacteria that cause periodontal disease. Moreover, in 2019, it was found that MGDG contained in Coccomyxa sp. KJ breaks the envelope membranes(3) of herpesviruses and has a virucidal effect against the viruses.

Recently, the three universities and DENSO discovered that MGDG contained in Coccomyxa sp. KJ also has a virucidal effect against COVID-19. The group will also research whether this microalga MGDG has a virucidal effect against influenza viruses, human coronaviruses, and other viruses with envelope membranes other than herpesviruses and COVID-19.

The results of the research may lead to the development of products that effectively counter COVID-19 and other viruses. The three universities and DENSO will continue to conduct this research to expand the scope of measures for preventing infectious diseases to contribute to society.

As an academia-industry collaboration project with the grant number JPMJTR204H, the research was conducted with support from the Adaptable and Seamless Technology Transfer Program through Target-driven R&D (A-STEP) funded by the Japan Science and Technology Agency (JST).
Glossary

(1) Coccomyxa sp. KJ is a registered trademark of DENSO Corporation. This microalga was developed by DENSO jointly with Kyoto University. "Stories," one of the DENSO-owned media, also features the plant: bit.ly/3JDGt38
(2) Virucidal effect means destroying the ability of viruses to infect cells.
(3) Envelope membranes are found in virus particles.


Topic: Press release summary
Source: Denso

Sectors: BioTech, Healthcare & Pharm, Clinical Trials
http://www.acnnewswire.com
From the Asia Corporate News Network


Copyright © 2024 ACN Newswire. All rights reserved. A division of Asia Corporate News Network.


Denso Links

http://www.globaldenso.com/en/

https://www.facebook.com/DENSOCorporation/

https://twitter.com/hashtag/denso?lang=en

https://www.youtube.com/channel/UCl8cZy9vYlTcnkVMEInM7XQ

https://ph.linkedin.com/company/denso

Denso
Oct 29, 2024 12:03 HKT/SGT
DENSO and U.S. Startup Quadric Sign Development License Agreement for AI Semiconductor (NPU)
Oct 1, 2024 08:27 HKT/SGT
DENSO and ROHM Agree to Start Consideration of Strategic Partnership in the Semiconductor Field
Sept 30, 2024 12:22 HKT/SGT
DENSO Announces Changes of Executive Responsibility and Executive Officers
Sept 16, 2024 18:54 HKT/SGT
DENSO Wins Medals at 47th WorldSkills Competition
Sept 13, 2024 08:59 HKT/SGT
DENSO to Transfer All Its NiPPA Shares to Nippon Mirai Capital
Sept 9, 2024 16:15 HKT/SGT
DENSO to Build a New Plant at the Zenmyo Plant
Sept 5, 2024 16:41 HKT/SGT
DENSO Fukushima Launches Production of Inverters
Aug 6, 2024 19:21 HKT/SGT
DENSO Signs Manufacturing License Agreement for SOEC Cell Stacks with Ceres Power Holdings of the UK
Aug 5, 2024 12:21 HKT/SGT
DENSO and JERA to Jointly Develop High-Efficiency Hydrogen Generation Technology that Combines SOEC with Waste Heat Utilization and to Conduct Joint Demonstration Testing at a JERA Thermal Power Station
July 15, 2024 14:05 HKT/SGT
DENSO Hosts Software Strategy Briefing, Shares Company Direction
More news >>
 News Alerts
Copyright © 2024 ACN Newswire - Asia Corporate News Network
Home | About us | Services | Partners | Events | Login | Contact us | Privacy Policy | Terms of Use | RSS
US: +1 214 890 4418 | China: +86 181 2376 3721 | Hong Kong: +852 8192 4922 | Singapore: +65 6549 7068 | Tokyo: +81 3 6859 8575

Connect With us: